SOURCE: Parenteral Drug Association

 

BETHESDA, MD--(Marketwire - August 20, 2008) - Today, the Parenteral Drug Association (PDA) announced that Janet Woodcock, MD, Director, CDER, FDA will give the keynote presentation September 8th during the Opening Plenary Session of the 2008 PDA/FDA Joint Regulatory Conference (www.pda.org/pdafda2008).

Woodcock will join Emer Cooke, Head, Inspections Sector, EMEA; Tang Minhai, Deputy Director, SHFDA; and Roger Williams, MD, Executive Vice President and CEO, USP to speak about the initiatives being taken by their respective agencies to implement modernization changes needed to achieve global harmonization.

To date, more than 30 FDA speakers and other regulatory representatives will be present at the 2008 PDA/FDA Joint Regulatory Conference to speak on topics related to Harmonization, Implementation and Modernization: Achieving a Future Vision as it relates to the bio/pharmaceutical industry.

"The conference program will examine how regulatory and industry have partnered to ensure and maintain pharmaceutical quality, and identify the strategies that are working and those that need to be improved to achieve modernized quality systems," said PDA's President, Robert Myers.

The 2008 PDA/FDA Joint Regulatory Conference will be held in Washington, D.C., September 8-12, 2008, at the Renaissance Hotel. For more information, visit www.pda.org/pdafda2008.

About PDA

Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 11,000 members worldwide. More information about PDA is available at www.pda.org.